Showing 1 - 6 results of 6 for search 'Danilo Rocco', query time: 0.03s Refine Results
  1. 1
    Neoadjuvant immunotherapy for lung cancer and hilar fibrosis during thoracoscopic lobectomy: Can we improve postoperative outcomes?

    Neoadjuvant immunotherapy for lung cancer and hilar fibrosis during thoracoscopic lobectomy: Can we improve postoperative outcomes? by Dario Amore, Dino Casazza, Umberto Caterino, Danilo Rocco, Carlo Bergaminelli

    Published 2024-10-01
    Get full text
    Article
  2. 2
    Liquid Biopsy in <i>EGFR</i>-Mutated Advanced NSCLC from T790M to <i>MET</i> Amplification: Clinical Implications and Possibilities in the Resistance Setting

    Liquid Biopsy in <i>EGFR</i>-Mutated Advanced NSCLC from T790M to <i>MET</i> Amplification: Clinical Implications and Possibilities in the Resistance Setting by Luigi Della Gravara, Ciro Battiloro, Aniello Avellino, Francesca Caputo, Carmine D’Aniello, Danilo Rocco

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients

    Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients by Luigi Della Gravara, Ciro Battiloro, Antonietta Letizia, Rosa Cantile, Vito D'Agnano, Giacomo Sica, Danilo Rocco

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution

    Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution by Caterina de Luca, Gianluca Russo, Mariantonia Nacchio, Maria Ingenito, Lucia Palumbo, Gianluca Gragnano, Floriana Conticelli, Maria Russo, Danilo Rocco, Cesare Gridelli, Roberto Bianco, Domenico Galetta, Giancarlo Troncone, Paola Parente, Antonino Iaccarino

    Published 2023-12-01
    Get full text
    Article
  5. 5
    A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler

    A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler by Francesco Pepe, Gianluca Russo, Nadia Barraco, Marco Bono, Angela Listì, Luisella Righi, Dario de Biase, Thais Maloberti, Claudia Scimone, Lucia Palumbo, Danilo Rocco, Giuseppina Roscigno, Enzo Gallo, Simonetta Buglioni, Michelina Coco, Lucia Anna Muscarella, Giancarlo Troncone, Umberto Malapelle

    Published 2024-11-01
    Get full text
    Article
  6. 6
    Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

    Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation by Danilo Rocco, Alex Friedlaender, Alfredo Addeo, Diego Signorelli, Alessio Cortellini, Sebastiano Buti, Raffaele Giusti, Marcello Tiseo, Pietro Di Marino, Michele De Tursi, Federica Zoratto, Marco Russano, Marco Filetti, Francesca Rastelli, Rita Chiari, Biagio Ricciuti, Alain Gelibter, Mario Alberto Occhipinti, Giampiero Porzio, Corrado Ficorella, Emilio Bria, Alessandro Morabito, Giuseppe L Banna, Joachim GJV Aerts, Fausto Barbieri, Diego L Cortinovis, Maria R Migliorino, Annamaria Catino, Francesco Passiglia, Mariangela Torniai, Carlo Genova, Francesca Mazzoni, Vincenzo Di Noia, Alessandro Inno, Giovanni Mansueto, Francesco Grossi, Pamela Pizzutilo, Fabrizio Citarella, Luca Cantini, Giada Targato, Olga Nigro, Miriam G Ferrara, Simona Scodes, Lorenza Landi, Giorgia Guaitoli, Luigi Della Gravara, Fabrizio Tabbò, Serena Ricciardi, Alessandro De Toma, Fausto Petrelli

    Published 2020-10-01
    Get full text
    Article

Search Tools: